title: Effects of decyl-aurachin D and reversed electron transfer in cytochrome bd.
abstract: Decyl-aurachin D is a near-stoichiometric inhibitor of cytochrome bd from Azotobacter vinelandii. Interaction of decyl-aurachin D with the oxidase induces a redshift of the alpha-band and Soret band of a b-type cytochrome, probably b-558, suggesting close proximity of the inhibitor binding site to this haem and hence to the proposed quinol binding domain. The compound does not affect the oxygen binding site directly as judged from unchanged CO recombination kinetics to haem d in dithionite-reduced enzyme. Although in the presence of ubiquinol-1 a decyl-aurachin D containing sample generates levels of haem reduction and catalytic intermediates similar to the control, the approach to this steady state is severely inhibited. In addition to the spectral effect on b-558, decyl-aurachin D raises the midpoint potential of haem b-558, but also lowers that of haem b-595. Consistent with the shift in midpoint potentials, electron backflow from haem d to the b-type haems can be observed in decyl-aurachin D inhibited samples following photolysis of the mixed-valence CO-ligated form of the enzyme. The data show that decyl-aurachin D acts on the donor side of haem b-558 without substantially affecting internal electron transfer rates or the oxygen reduction site.
authors.affiliation: Glynn Research Institute, Bodmin, Cornwall PL30 4AU, U.K., and King's College London, Camden Hill Road, London W8 7AH, U.K.
authors.forename: S
authors.initials: S
authors.lastname: Jünemann
authors.forename: J M
authors.initials: JM
authors.lastname: Wrigglesworth
authors.forename: P R
authors.initials: PR
authors.lastname: Rich
mesh_terms: D016948:Azotobacter vinelandii / Q000201:enzymology; D002248:Carbon Monoxide / Q000378:metabolism; D003573:Cytochrome b Group; D003580:Cytochromes / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D004579:Electron Transport; D045222:Electron Transport Chain Complex Proteins; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D029968:Escherichia coli Proteins; D006418:Heme / Q000378:metabolism; D007700:Kinetics; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism; D015363:Quinolones / Q000494:pharmacology; D013329:Structure-Activity Relationship
chemical_list: D003573:Cytochrome b Group; D003580:Cytochromes; D045222:Electron Transport Chain Complex Proteins; D004791:Enzyme Inhibitors; D029968:Escherichia coli Proteins; D015363:Quinolones; C052097:aurachin D; D006418:Heme; D002248:Carbon Monoxide; D010088:Oxidoreductases; C040077:cytochrome bd terminal oxidase complex, E coli